These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

313 related items for PubMed ID: 20181712

  • 1. Sumoylation of the Epstein-Barr virus BZLF1 protein inhibits its transcriptional activity and is regulated by the virus-encoded protein kinase.
    Hagemeier SR, Dickerson SJ, Meng Q, Yu X, Mertz JE, Kenney SC.
    J Virol; 2010 May; 84(9):4383-94. PubMed ID: 20181712
    [Abstract] [Full Text] [Related]

  • 2. Epstein-barr virus immediate-early protein BZLF1 is SUMO-1 modified and disrupts promyelocytic leukemia bodies.
    Adamson AL, Kenney S.
    J Virol; 2001 Mar; 75(5):2388-99. PubMed ID: 11160742
    [Abstract] [Full Text] [Related]

  • 3. The B-cell specific transcription factor, Oct-2, promotes Epstein-Barr virus latency by inhibiting the viral immediate-early protein, BZLF1.
    Robinson AR, Kwek SS, Kenney SC.
    PLoS Pathog; 2012 Feb; 8(2):e1002516. PubMed ID: 22346751
    [Abstract] [Full Text] [Related]

  • 4. Cellular differentiation regulator BLIMP1 induces Epstein-Barr virus lytic reactivation in epithelial and B cells by activating transcription from both the R and Z promoters.
    Reusch JA, Nawandar DM, Wright KL, Kenney SC, Mertz JE.
    J Virol; 2015 Feb; 89(3):1731-43. PubMed ID: 25410866
    [Abstract] [Full Text] [Related]

  • 5. Effects of targeting sumoylation processes during latent and induced Epstein-Barr virus infections using the small molecule inhibitor ML-792.
    Garcia P, Harrod A, Jha S, Jenkins J, Barnhill A, Lee H, Thompson M, Williams JP, Barefield J, Mckinnon A, Suarez P, Shah A, Lowrey AJ, Bentz GL.
    Antiviral Res; 2021 Apr; 188():105038. PubMed ID: 33577806
    [Abstract] [Full Text] [Related]

  • 6. Ubiquitin Modification of the Epstein-Barr Virus Immediate Early Transactivator Zta.
    Zhao M, Nanbo A, Becnel D, Qin Z, Morris GF, Li L, Lin Z.
    J Virol; 2020 Oct 27; 94(22):. PubMed ID: 32847852
    [Abstract] [Full Text] [Related]

  • 7. LMP1-Induced Sumoylation Influences the Maintenance of Epstein-Barr Virus Latency through KAP1.
    Bentz GL, Moss CR, Whitehurst CB, Moody CA, Pagano JS.
    J Virol; 2015 Aug 27; 89(15):7465-77. PubMed ID: 25948750
    [Abstract] [Full Text] [Related]

  • 8. Epstein-Barr virus (EBV) SM protein induces and recruits cellular Sp110b to stabilize mRNAs and enhance EBV lytic gene expression.
    Nicewonger J, Suck G, Bloch D, Swaminathan S.
    J Virol; 2004 Sep 27; 78(17):9412-22. PubMed ID: 15308735
    [Abstract] [Full Text] [Related]

  • 9. Transcriptional repression by sumoylation of Epstein-Barr virus BZLF1 protein correlates with association of histone deacetylase.
    Murata T, Hotta N, Toyama S, Nakayama S, Chiba S, Isomura H, Ohshima T, Kanda T, Tsurumi T.
    J Biol Chem; 2010 Jul 30; 285(31):23925-35. PubMed ID: 20516063
    [Abstract] [Full Text] [Related]

  • 10. BZLF1 activation of the methylated form of the BRLF1 immediate-early promoter is regulated by BZLF1 residue 186.
    Bhende PM, Seaman WT, Delecluse HJ, Kenney SC.
    J Virol; 2005 Jun 30; 79(12):7338-48. PubMed ID: 15919888
    [Abstract] [Full Text] [Related]

  • 11. Differentiation-Dependent LMP1 Expression Is Required for Efficient Lytic Epstein-Barr Virus Reactivation in Epithelial Cells.
    Nawandar DM, Ohashi M, Djavadian R, Barlow E, Makielski K, Ali A, Lee D, Lambert PF, Johannsen E, Kenney SC.
    J Virol; 2017 Apr 15; 91(8):. PubMed ID: 28179525
    [Abstract] [Full Text] [Related]

  • 12. Viral genome methylation differentially affects the ability of BZLF1 versus BRLF1 to activate Epstein-Barr virus lytic gene expression and viral replication.
    Wille CK, Nawandar DM, Panfil AR, Ko MM, Hagemeier SR, Kenney SC.
    J Virol; 2013 Jan 15; 87(2):935-50. PubMed ID: 23135711
    [Abstract] [Full Text] [Related]

  • 13. The B-cell-specific transcription factor and master regulator Pax5 promotes Epstein-Barr virus latency by negatively regulating the viral immediate early protein BZLF1.
    Raver RM, Panfil AR, Hagemeier SR, Kenney SC.
    J Virol; 2013 Jul 15; 87(14):8053-63. PubMed ID: 23678172
    [Abstract] [Full Text] [Related]

  • 14. Fatty acid synthase expression is induced by the Epstein-Barr virus immediate-early protein BRLF1 and is required for lytic viral gene expression.
    Li Y, Webster-Cyriaque J, Tomlinson CC, Yohe M, Kenney S.
    J Virol; 2004 Apr 15; 78(8):4197-206. PubMed ID: 15047835
    [Abstract] [Full Text] [Related]

  • 15. Hippo signaling effectors YAP and TAZ induce Epstein-Barr Virus (EBV) lytic reactivation through TEADs in epithelial cells.
    Van Sciver N, Ohashi M, Pauly NP, Bristol JA, Nelson SE, Johannsen EC, Kenney SC.
    PLoS Pathog; 2021 Aug 15; 17(8):e1009783. PubMed ID: 34339458
    [Abstract] [Full Text] [Related]

  • 16. Cellular transcription factor Oct-1 interacts with the Epstein-Barr virus BRLF1 protein to promote disruption of viral latency.
    Robinson AR, Kwek SS, Hagemeier SR, Wille CK, Kenney SC.
    J Virol; 2011 Sep 15; 85(17):8940-53. PubMed ID: 21697476
    [Abstract] [Full Text] [Related]

  • 17. Functional and physical interactions between the Epstein-Barr virus (EBV) proteins BZLF1 and BMRF1: Effects on EBV transcription and lytic replication.
    Zhang Q, Hong Y, Dorsky D, Holley-Guthrie E, Zalani S, Elshiekh NA, Kiehl A, Le T, Kenney S.
    J Virol; 1996 Aug 15; 70(8):5131-42. PubMed ID: 8764021
    [Abstract] [Full Text] [Related]

  • 18. Ceramide promotes lytic reactivation of Epstein-Barr virus in gastric carcinoma.
    Kim JY, Min YJ, Lee M-H, An YR, Ashktorab H, Smoot DT, Kwon SW, Lee SK.
    J Virol; 2024 Feb 20; 98(2):e0177623. PubMed ID: 38197630
    [Abstract] [Full Text] [Related]

  • 19. Epstein-Barr virus BZLF1 gene, a switch from latency to lytic infection, is expressed as an immediate-early gene after primary infection of B lymphocytes.
    Wen W, Iwakiri D, Yamamoto K, Maruo S, Kanda T, Takada K.
    J Virol; 2007 Jan 20; 81(2):1037-42. PubMed ID: 17079287
    [Abstract] [Full Text] [Related]

  • 20. B cells infected with Type 2 Epstein-Barr virus (EBV) have increased NFATc1/NFATc2 activity and enhanced lytic gene expression in comparison to Type 1 EBV infection.
    Romero-Masters JC, Huebner SM, Ohashi M, Bristol JA, Benner BE, Barlow EA, Turk GL, Nelson SE, Baiu DC, Van Sciver N, Ranheim EA, Gumperz J, Sherer NM, Farrell PJ, Johannsen EC, Kenney SC.
    PLoS Pathog; 2020 Feb 20; 16(2):e1008365. PubMed ID: 32059024
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.